DEPARTMENT OF DEFENSE - CONGRESSIONALLY DIRECTED MEDICAL RESEARCH PROGRAMS
  1. Home
  2. Funding Opportunities
  3. Synopsis of Open Program Funding Opportunities

Funding Opportunities

Synopsis of Open Program Funding Opportunities

FY21 Alcohol and Substance Abuse Disorders Research Program (ASADRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Consortium Award Program Announcement
Application Instructions
 June 16, 2021
  • The maximum period of performance is 5 years.
  • The CDMRP expects to allocate FY21-23 funding, if appropriated, to fund approximately one ASADRP Consortium Award.
  • The ASADRP Consortium will be funded initially with allocations from the FY21 ASADRP congressional appropriation ($3.525M).
  • The maximum allowable total costs (direct and indirect) for the entire period of performance are $10.575M (initial period of performance plus 2 options).
  • Two additional options, to be included in the application, may be funded from allocations from the FY22 and FY23 congressional appropriation (up to $3.525M each year) subject to Programmatic Panel review, approval of the Grants Officer, and receipt of future congressional appropriations.
 Pre-Application (Letter of Intent):
August 18, 2021

Application:
September 8, 2021

FY21 Breast Cancer Research Program (BCRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Breakthrough Award Levels 1 and 2 II Program Announcement
Application Instructions
 April 26, 2021 Funding Level 1:
  • Maximum funding of $450,000 for direct costs (plus indirect costs).
  • The maximum period of performance is 3 years.

Funding Level 1 with Partnering PI Option:

  • Maximum funding of $750,000 for direct costs (plus indirect costs).
  • The maximum period of performance is 3 years.

Funding Level 2:

  • Maximum funding of $1 million (M) for direct costs (plus indirect costs).
  • The maximum period of performance is 3 years.

Funding Level 2 – Population Science and Prevention Studies:

  • Maximum funding of $1.5M for direct costs (plus indirect costs).
  • The maximum period of performance is 4 years.

Funding Level 2 with Partnering PI Option:

  • Maximum funding of $1.5M for direct costs (plus indirect costs).
  • The maximum period of performance is 3 years.

Funding Level 2 – Population Science and Prevention Studies – Partnering PI Option:

  • Maximum funding of $2M for direct costs (plus indirect costs).
  • The maximum period of performance is 4 years.
 Pre-Application (Letter of Intent): August 31, 2021

Application: September 14, 2021
Era of Hope Scholar Award II Program Announcement
Application Instructions
 April 26, 2021
  • Maximum funding of $3M for direct costs (plus indirect costs).
  • The maximum period of performance is 4 years.
 Pre-Application (Letter of Intent): August 31, 2021

Application: September 14, 2021

Confidential Letters of Recommendation Submission Deadline: September 17, 2021


FY21 Combat Readiness – Medical Research Program (CRRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Rapid Development and Translational Research Award Extramural applicants:
Broad Agency Announcement
General Submission Instructions

Intramural applicants:
Program Announcement Announcement 		July 16, 2021 RDTRA:
  • Maximum funding of $1,800,000 for total costs (to include direct and indirect costs).
  • Maximum period of performance is 2 years.
RDTRA with Option:
  • Maximum funding of $1,800,000 (RDTRA) and 1,000,000 (Option) for total costs (to include direct and indirect costs).
  • Maximum period of performance is 2 years for the RDTRA base award and 1 year for the Option.
 Pre-Application (Preproposal):
August 31, 2021

Proposal/Application:
December 1, 2021


DMDRP

FY21 Duchenne Muscular Dystrophy Research Program (DMDRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Idea Development Award Program Announcement
Application Instructions 		May 27, 2021
  • Maximum funding of $350,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 2 years.
 Pre-Application:
August 11, 2021

Preproposal is required; application submission is by invitation only.

Application:
December 1, 2021
Translational Research Award Program Announcement
Application Instructions 		May 27, 2021
  • Maximum funding of $1,300,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 3 years.
 Pre-Application:
August 11, 2021

Preproposal is required; application submission is by invitation only.

Application:
December 1, 2021


FY21 Kidney Cancer Research Program (KCRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Academy of Kidney Cancer Investigators – Early-Career Investigator Award Program Announcement
Application Instructions 		June 14, 2021
  • Maximum funding of $725,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 4 years.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
 Pre-Application (Letter of Intent):
September 14, 2021

Application:
October 5, 2021
Clinical Research Nurse Development Award Program Announcement
Application Instructions 		June 14, 2021
  • Maximum funding of $300,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 2 years.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
 Pre-Application (Letter of Intent):
September 14, 2021

Application:
October 5, 2021
Clinical Trial Award Program Announcement
Application Instructions 		June 14, 2021
  • Maximum funding of $2,000,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 4 years.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
 Pre-Application (Letter of Intent):
September 14, 2021

Application:
October 5, 2021


LRP

FY21 Lupus Research Program (LRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Idea Award Program Announcement
Application Instructions
 April 26, 2021
  • The maximum allowable funding for the entire period of performance is $300,000 in total costs (direct plus indirect costs).
  • The maximum period of performance is 2 years.
 Pre-Application (Letter of Intent): August 24, 2021

Application: September 22, 2021
Impact Award Program Announcement
Application Instructions
 April 26, 2021
  • The maximum allowable funding for the entire period of performance is $750,000 in total costs (direct plus indirect costs).
  • The maximum period of performance is 4 years.
 Pre-Application (Letter of Intent): August 24, 2021

Application: September 22, 2021
Transformative Vision Award Program Announcement
Application Instructions
 April 26, 2021
  • The maximum allowable funding for the entire period of performance is $2,500,000 in total costs (direct plus indirect costs).
  • The maximum period of performance is 4 years.
 Pre-Application (Letter of Intent): August 24, 2021

Application: September 22, 2021


FY21 Melanoma Research Program (MRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Melanoma Academy Leadership Award Program Announcement
Application Instructions
 May 7, 2021
  • The maximum allowable funding for the entire period of performance is $1,300,000 for direct costs.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
  • The maximum period of performance is 4 years.
 Pre-Application (Letter of Intent):
August 4, 2021

Application:
August 26, 2021
Melanoma Academy Scholar Award Program Announcement
Application Instructions
 May 7, 2021
  • The maximum allowable funding for the entire period of performance is $500,000 for direct costs.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
  • The maximum period of performance is 4 years.
 Pre-Application (Letter of Intent):
August 4, 2021

Application:
August 26, 2021
Mid-Career Accelerator Award Program Announcement
Application Instructions
 May 7, 2021
  • The maximum allowable funding for the entire period of performance is $750,000 for direct costs.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
  • The maximum period of performance is 3 years.
 Pre-Application (Letter of Intent):
September 9, 2021

Application:
September 28, 2021
Team Science Award Program Announcement
Application Instructions
 May 7, 2021
  • The maximum allowable funding for the entire period of performance is $700,000 for direct costs.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
  • The maximum period of performance is 3 years.
 Pre-Application (Letter of Intent):
September 9, 2021

Application:
September 28, 2021
Translational Research Award Program Announcement
Application Instructions
 May 7, 2021
  • The maximum allowable funding for the entire period of performance is $600,000 for direct costs.
  • Collaboration Option: The maximum allowable funding for the entire period of performance is $700,000 for direct costs.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
  • The maximum period of performance is 3 years.
 Pre-Application (Letter of Intent):
September 9, 2021

Application:
September 28, 2021
MSRP

FY21 Multiple Sclerosis Research Program (MSRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Early Investigator Research Award Program Announcement
Application Instructions
 May 10, 2021
  • Maximum funding of $200,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 2 years.
 Pre-Application (Letter of Intent): September 7, 2021
Application: October 1, 2021


FY21 Neurotoxin Exposure Treatment Parkinson’s Research Program (NETP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Early Investigator Research Award Program Announcement
Application Instructions 		May 27, 2021
  • Maximum funding of $400,000 for total costs (includes direct and indirect costs).
  • Maximum period of performance is 2 years.
 Pre-Application (Letter of Intent):
Septemeber 8, 2021

Application:
September 29, 2021
Investigator-Initiated Research Award Program Announcement
Application Instructions 		May 27, 2021
  • Maximum funding of $1.2 million (M) for total costs (includes direct and indirect costs).
  • Maximum Period of performance is 3 years.
 Pre-Application (Letter of Intent):
Septemeber 8, 2021

Application:
September 29, 2021
Synergistic Idea Award Program Announcement
Application Instructions 		May 27, 2021
  • Maximum funding of $3 million (M) for total costs (includes direct and indirect costs).
  • Maximum Period of performance is 4 years.
 Pre-Application (Letter of Intent):
Septemeber 8, 2021

Application:
September 29, 2021




FY21 Prostate Cancer Research Program (PCRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Idea Development Award Program Announcement
Application Instructions 		April 5, 2021
  • The maximum allowable funding for the entire period of performance is $750,000 for direct costs.
  • The maximum period of performance is 3 years.
 Pre-application (Letter of Intent): September 2, 2021

Application: September 23, 2021
Clinical Consortium Award Program Announcement
Application Instructions 		April 8, 2021 Coordinating Center:
  • Maximum funding of $7,200,000 for direct costs (plus indirect costs), including no less than $500,000 per year for support of two or more Affiliate Clinical Research Sites.
  • Maximum period of performance is 4 years.

Clinical Sites:

  • Maximum funding of $1,200,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 4 years
 Pre-Application (Letter of Intent): September 2, 2021

Application: September 23, 2021

FY21 Scleroderma Research Program (SRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Idea Development Award Program Announcement
Application Instructions 		May 14, 2021 The maximum allowable funding for the entire period of performance is $300,000 for direct costs.

New Investigator Collaboration Option:

  • The maximum allowable funding for the entire period of performance is $450,000 for direct costs.
  • At least fifty percent of the funding must be allocated to the new investigator.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
  • The maximum period of performance is 3 years.
 Pre-Application (Letter of Intent): August 11, 2021

Application:
August 25, 2021
Translational Research Partnership Award Program Announcement
Application Instructions 		May 14, 2021
  • The maximum period of performance is 3 years.
  • The maximum allowable funding for the entire period of performance is $750,000 in direct costs.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
 Pre-Application (Letter of Intent): August 11, 2021

Application:
August 25, 2021




Last updated Sunday, August 1, 2021